Matthew Herder
Overview
Explore the profile of Matthew Herder including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
47
Citations
180
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
2.
Herder M, Benavides X
PLOS Glob Public Health
. 2024 Sep;
4(9):e0003173.
PMID: 39312552
In June 2021 the World Health Organization (WHO) and the Medicines Patent Pool (MPP) launched an mRNA technology transfer programme. With a South African consortium serving as the hub, the...
3.
4.
5.
Grundy Q, Campbell C, Ali R, Herder M, Holloway K
J Law Med Ethics
. 2024 May;
52(1):80-97.
PMID: 38818600
Interventional clinical studies of convalescent plasma to treat COVID-19 were predominantly funded and led by public sector actors, including blood services operators. We aimed to analyze the processes of clinical...
6.
7.
Herder M
J Law Med Ethics
. 2024 Mar;
51(4):900-919.
PMID: 38477277
The US Food and Drug Administration's controversial decision to grant accelerated approval to aducanumab (Aduhelm), a therapy for Alzheimer's disease, has motivated multiple policy reforms. Drawing a case series of...
8.
Bai I, Doshi P, Herder M
BMJ Evid Based Med
. 2023 Oct;
29(3):187-193.
PMID: 37898504
Incorporating clinical data held by national health product regulatory authorities into secondary analyses such as systematic reviews can help combat publication bias and selective outcome reporting, in turn, supporting more...
9.
Eren Vural I, Herder M, Doll A, Graham J
Int J Health Policy Manag
. 2023 Aug;
12:6936.
PMID: 37579382
Background: Analysing the Canadian government's efforts to support the development of COVID-19 "medical countermeasures" (MCMs), this article seeks insights into political economy as a driver of pandemic response. We explore...
10.
Lynch H, Sachs R, Lee S, Herder M, Ross J, Ramachandran R
JAMA Health Forum
. 2023 Jun;
4(6):e231313.
PMID: 37294583
Importance: The US Food and Drug Administration (FDA) has expansive regulatory flexibility regarding the quality and quantity of evidence it deems sufficient to approve new drugs, which has been increasingly...